跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Inotuzumab Ozogamicin for Injection
Approved
生物制品
Inotuzumab Ozogamicin for Injection
WYETH PHARMACEUTICALS LLC
🇨🇳 National Medical Products Administration
Approval Date
Dec 20, 2021
Approval ID
8DqcDqcvhOL
Company
WYETH PHARMACEUTICALS LLC
Type
生物制品
Approval Details
Approval Id
8DqcDqcvhOL
Approval Number
国药准字SJ20210033
Generic Name
注射用奥加伊妥珠单抗
Generic Name En
Inotuzumab Ozogamicin for Injection
Trade Name
贝博萨
Drug Type
生物制品
Dosage Form
注射剂
Strength
1.0 mg/瓶
Reg Date
2021-12-20
Expired Date
2026-12-19
Company Name
WYETH PHARMACEUTICALS LLC
Company Detail Path
/organization/wyeth-pharmaceuticals-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 20, 2021
Approval ID
8DqcDqcvhOL
Type
生物制品
Back to NMPA Approvals
贝博萨 - NMPA Drug Approval Details